What did @lagosgirliesroom actually say?
The creator claims she is revealing where Lagos women are secretly getting "weight loss injections" that cause people to drop "7 to 10 kg in 30 days without killing themselves in the gym or starving." She identifies the product as "the same compound" as tirzepatide, available in Nigeria through a service called Dokitami, supervised by a verified doctor.
She also frames the weight loss as a financial strategy: "You can't be looking out of shape or obese and expect to see a man who has spent the company on you invest in looking good to get return on investment." That framing is worth naming directly because it ties body composition to relationship worth, which is a separate problem from the medical claims, but it shapes why someone might skip the safety questions entirely.
The pitch ends with urgency: "Don't dawl. If you've been waiting for a sign, this is it." That is a classic direct-response sales technique, not a medical consultation.
Does the science back this up?
Tirzepatide is a real drug with strong clinical evidence. The claim that it produces rapid weight loss is not invented. But the specific numbers and timeline deserve scrutiny, and the "no diet, no exercise" framing misrepresents what the trials actually showed.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed participants on the highest dose of tirzepatide lost an average of 20.9% of body weight over 72 weeks. That is roughly 18 months. The dramatic early losses seen in some individuals, sometimes 3, 5 kg in the first four weeks, are partly water weight and glycogen depletion, not pure fat loss. Losing 7, 10 kg of actual fat in 30 days on any GLP-1 or GIP/GLP-1 agonist is not a typical or expected outcome. It is not impossible in a heavier individual with fluid changes, but advertising it as a standard result is misleading.
The SURMOUNT trials also included lifestyle counseling. Participants were not eating freely. Presenting tirzepatide as a replacement for dietary change contradicts the study conditions that produced those results.
What did they get wrong (or right)?
Credit where it is due: tirzepatide does work as a weight management agent, and the existence of compounded versions in markets outside the US and EU is a real phenomenon. Calling it "the same compound" as a branded product is where things go wrong legally and clinically. Compounded tirzepatide is not the same as Zepbound or Mounjaro in terms of regulatory approval, manufacturing standards, or verified bioequivalence. The FDA has been explicit about this distinction.
The "7 to 10 kg in 30 days" claim lacks a cited source. No peer-reviewed trial reports that as an average outcome at four weeks. It may reflect outlier anecdotes or marketing copy.
The framing of "no crash diets" is also inaccurate. GLP-1 and GIP agonists work partly by reducing appetite and slowing gastric emptying, which means users naturally eat less. Calling that "no dieting" is technically misleading: the drug produces the caloric deficit that a diet would otherwise require. Users still need adequate protein and nutritional guidance to avoid muscle loss, as shown in Wilding et al., 2021, NEJM, where lean mass loss was a documented concern.
What should you actually know?
Tirzepatide is a legitimate, evidence-backed medication. If you are considering it, the access pathway matters as much as the molecule. The creator mentions a "real MDC and verified doctor" but provides no details about what that supervision involves, how dosing is determined, or what monitoring is required.
GLP-1 and GIP agonists carry real side effects including nausea, vomiting, pancreatitis risk, and potential thyroid concerns flagged in animal studies (though not confirmed in humans at therapeutic doses per the SURMOUNT safety data). Starting without baseline bloodwork or a proper medical history review is a risk, not a shortcut.
Compounded peptides also vary in quality. Without knowing the source, concentration, and sterility standards of what Dokitami is dispensing, there is no way to verify the product matches what it claims to be. That is not a reason to dismiss compounding categorically, but it is a reason to ask harder questions before injecting anything.
If you are in Nigeria and genuinely interested in GLP-1 therapy, seek a consultation with a licensed physician who can review your metabolic health, contraindications, and goals before any prescription is written.